시장보고서
상품코드
1432267

세계의 펩티드 원료의약품 CDMO 서비스 시장 : 인사이트 및 예측(-2030년)

Global Peptide API CDMO Services Market Insights, Forecast to 2030

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 23억 4,221만 달러에서 2030년에는 54억 4,797만 달러로 성장할 것으로 예측되며, 예측 기간중 연간 평균 성장률(CAGR)은 15.11%를 나타낼 전망입니다.

미국/캐나다의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 12억 1,966만 달러에서 2030년에는 27억 5,100만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 14.52%를 나타낼 전망입니다.

중국의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 2억 566만 달러에서 2030년에는 6억 3,865만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 20.79%를 나타낼 전망입니다.

유럽의 펩티드 원료의약품 CDMO 서비스 시장 규모는 2024년 7억 5,896만 달러에서 2030년에는 16억 5,534만 달러로 성장할 것으로 예측되며, 2024년부터 2030년 예측 기간 중 연평균 복합 성장률(CAGR)은 13.88%를 나타낼 전망입니다.

펩티드 원료의약품 CDMO 서비스 세계 주요 기업에는 Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company등이 있습니다. 2023년, 세계 주요 5개사의 매출 점유율은 약 54.92%였습니다.

세계의 펩티드 원료의약품 CDMO 서비스 시장에 대해 조사했으며, 시장 개요와 함께, 기업별/유형별/용도별/지역별 동향 및 시장 진출기업 개요 등을 제공합니다.

목차

제1장 보고서 개요

  • 조사 범위
  • 유형별 시장 분석
  • 용도별 시장
  • 전제와 제한
  • 조사 목적
  • 대상년

제2장 세계의 성장 동향

  • 세계의 펩티드 원료의약품 CDMO 서비스 시장 전망(2019년-2030년)
  • 세계 펩티드 원료의약품 CDMO 서비스 성장 동향, 지역별
  • 펩티드 원료의약품 CDMO 서비스 시장 역학

제3장 주요 시장 진출기업의 경쟁 구도

제4장 펩티드 원료의약품 CDMO 서비스 분석 데이터, 유형별

  • 세계의 펩티드 원료의약품 CDMO 서비스 시장 규모 실적(2019년-2024년), 유형별
  • 세계의 펩티드 원료의약품 CDMO 서비스 시장 규모 예측(2025년-2030년), 유형별

제5장 펩티드 원료의약품 CDMO 서비스 분석 데이터, 용도별

  • 세계의 펩티드 원료의약품 CDMO 서비스 시장 규모 실적(2019년-2024년), 용도별
  • 세계의 펩티드 원료의약품 CDMO 서비스 시장 규모 예측(2025년-2030년), 용도별

제6장 북미

제7장 유럽

제8장 중국

제9장 아시아(중국 제외)

제10장 중동 및 아프리카, 라틴아메리카

제11장 주요 진출 기업 개요

  • Bachem
  • PolyPeptide
  • CordenPharma
  • AmbioPharm
  • USV Peptides
  • Thermo Fisher
  • Bio Basic
  • JPT
  • Genscript
  • Chinese Peptide Company
  • ScinoPharm
  • ChengDu ShengNuo Biotec
  • CBL
  • Piramal Pharma
  • CPC Scientific

제12장 애널리스트의 견해/결론

제13장 부록

LSH 24.03.05

The global Peptide API CDMO Services market is projected to grow from US$ 2342.21 million in 2024 to US$ 5447.97 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.11% during the forecast period.

The US & Canada market for Peptide API CDMO Services is estimated to increase from $ 1219.66 million in 2024 to reach $ 2751.00 million by 2030, at a CAGR of 14.52% during the forecast period of 2024 through 2030.

The China market for Peptide API CDMO Services is estimated to increase from $ 205.66 million in 2024 to reach $ 638.65 million by 2030, at a CAGR of 20.79% during the forecast period of 2024 through 2030.

The Europe market for Peptide API CDMO Services is estimated to increase from $ 758.96 million in 2024 to reach $ 1655.34 million by 2030, at a CAGR of 13.88% during the forecast period of 2024 through 2030.

The global key companies of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc. In 2023, the global top five players had a share approximately 54.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Peptide API CDMO Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Peptide API CDMO Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peptide API CDMO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide API CDMO Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide API CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peptide API CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc.

Market Segmentation

By Company

  • Bachem
  • PolyPeptide
  • CordenPharma
  • AmbioPharm
  • USV Peptides
  • Thermo Fisher
  • Bio Basic
  • JPT
  • Genscript
  • Chinese Peptide Company
  • ScinoPharm
  • ChengDu ShengNuo Biotec
  • CBL
  • Piramal Pharma
  • CPC Scientific

Segment by Type

  • GMP Services
  • Non-GMP Services

Segment by Application

  • Commercial
  • Scientific Research
  • Other

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Israel
  • GCC Countries
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Peptide API CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide API CDMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide API CDMO Services revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Peptide API CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 GMP Services
    • 1.2.3 Non-GMP Services
  • 1.3 Market by Application
    • 1.3.1 Global Peptide API CDMO Services Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Commercial
    • 1.3.3 Scientific Research
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peptide API CDMO Services Market Perspective (2019-2030)
  • 2.2 Global Peptide API CDMO Services Growth Trends by Region
    • 2.2.1 Global Peptide API CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Peptide API CDMO Services Historic Market Size by Region (2019-2024)
    • 2.2.3 Peptide API CDMO Services Forecasted Market Size by Region (2025-2030)
  • 2.3 Peptide API CDMO Services Market Dynamics
    • 2.3.1 Peptide API CDMO Services Industry Trends
    • 2.3.2 Peptide API CDMO Services Market Drivers
    • 2.3.3 Peptide API CDMO Services Market Challenges
    • 2.3.4 Peptide API CDMO Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Peptide API CDMO Services by Players
    • 3.1.1 Global Peptide API CDMO Services Revenue by Players (2019-2024)
    • 3.1.2 Global Peptide API CDMO Services Revenue Market Share by Players (2019-2024)
  • 3.2 Global Peptide API CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Peptide API CDMO Services, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Peptide API CDMO Services Market Concentration Ratio
    • 3.4.1 Global Peptide API CDMO Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 3 and Top 5 Companies by Peptide API CDMO Services Revenue in 2023
  • 3.5 Global Key Players of Peptide API CDMO Services Head office and Area Served
  • 3.6 Global Key Players of Peptide API CDMO Services, Product and Application
  • 3.7 Global Key Players of Peptide API CDMO Services Established Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide API CDMO Services Breakdown Data by Type

  • 4.1 Global Peptide API CDMO Services Historic Market Size by Type (2019-2024)
  • 4.2 Global Peptide API CDMO Services Forecasted Market Size by Type (2025-2030)

5 Peptide API CDMO Services Breakdown Data by Application

  • 5.1 Global Peptide API CDMO Services Historic Market Size by Application (2019-2024)
  • 5.2 Global Peptide API CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Peptide API CDMO Services Market Size (2019-2030)
  • 6.2 North America Peptide API CDMO Services Market Size by Type
    • 6.2.1 North America Peptide API CDMO Services Market Size by Type (2019-2024)
    • 6.2.2 North America Peptide API CDMO Services Market Size by Type (2025-2030)
    • 6.2.3 North America Peptide API CDMO Services Market Share by Type (2019-2030)
  • 6.3 North America Peptide API CDMO Services Market Size by Application
    • 6.3.1 North America Peptide API CDMO Services Market Size by Application (2019-2024)
    • 6.3.2 North America Peptide API CDMO Services Market Size by Application (2025-2030)
    • 6.3.3 North America Peptide API CDMO Services Market Share by Application (2019-2030)
  • 6.4 North America Peptide API CDMO Services Market Size by Country
    • 6.4.1 North America Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Peptide API CDMO Services Market Size by Country (2019-2024)
    • 6.4.3 North America Peptide API CDMO Services Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Peptide API CDMO Services Market Size (2019-2030)
  • 7.2 Europe Peptide API CDMO Services Market Size by Type
    • 7.2.1 Europe Peptide API CDMO Services Market Size by Type (2019-2024)
    • 7.2.2 Europe Peptide API CDMO Services Market Size by Type (2025-2030)
    • 7.2.3 Europe Peptide API CDMO Services Market Share by Type (2019-2030)
  • 7.3 Europe Peptide API CDMO Services Market Size by Application
    • 7.3.1 Europe Peptide API CDMO Services Market Size by Application (2019-2024)
    • 7.3.2 Europe Peptide API CDMO Services Market Size by Application (2025-2030)
    • 7.3.3 Europe Peptide API CDMO Services Market Share by Application (2019-2030)
  • 7.4 Europe Peptide API CDMO Services Market Size by Country
    • 7.4.1 Europe Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Peptide API CDMO Services Market Size by Country (2019-2024)
    • 7.4.3 Europe Peptide API CDMO Services Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia

8 China

  • 8.1 China Peptide API CDMO Services Market Size (2019-2030)
  • 8.2 China Peptide API CDMO Services Market Size by Type
    • 8.2.1 China Peptide API CDMO Services Market Size by Type (2019-2024)
    • 8.2.2 China Peptide API CDMO Services Market Size by Type (2025-2030)
    • 8.2.3 China Peptide API CDMO Services Market Share by Type (2019-2030)
  • 8.3 China Peptide API CDMO Services Market Size by Application
    • 8.3.1 China Peptide API CDMO Services Market Size by Application (2019-2024)
    • 8.3.2 China Peptide API CDMO Services Market Size by Application (2025-2030)
    • 8.3.3 China Peptide API CDMO Services Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Peptide API CDMO Services Market Size (2019-2030)
  • 9.2 Asia Peptide API CDMO Services Market Size by Type
    • 9.2.1 Asia Peptide API CDMO Services Market Size by Type (2019-2024)
    • 9.2.2 Asia Peptide API CDMO Services Market Size by Type (2025-2030)
    • 9.2.3 Asia Peptide API CDMO Services Market Share by Type (2019-2030)
  • 9.3 Asia Peptide API CDMO Services Market Size by Application
    • 9.3.1 Asia Peptide API CDMO Services Market Size by Application (2019-2024)
    • 9.3.2 Asia Peptide API CDMO Services Market Size by Application (2025-2030)
    • 9.3.3 Asia Peptide API CDMO Services Market Share by Application (2019-2030)
  • 9.4 Asia Peptide API CDMO Services Market Size by Region
    • 9.4.1 Asia Peptide API CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Peptide API CDMO Services Market Size by Region (2019-2024)
    • 9.4.3 Asia Peptide API CDMO Services Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Bachem
    • 11.1.1 Bachem Company Details
    • 11.1.2 Bachem Business Overview
    • 11.1.3 Bachem Peptide API CDMO Services Introduction
    • 11.1.4 Bachem Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.1.5 Bachem Recent Development
  • 11.2 PolyPeptide
    • 11.2.1 PolyPeptide Company Details
    • 11.2.2 PolyPeptide Business Overview
    • 11.2.3 PolyPeptide Peptide API CDMO Services Introduction
    • 11.2.4 PolyPeptide Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.2.5 PolyPeptide Recent Development
  • 11.3 CordenPharma
    • 11.3.1 CordenPharma Company Details
    • 11.3.2 CordenPharma Business Overview
    • 11.3.3 CordenPharma Peptide API CDMO Services Introduction
    • 11.3.4 CordenPharma Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.3.5 CordenPharma Recent Development
  • 11.4 AmbioPharm
    • 11.4.1 AmbioPharm Company Details
    • 11.4.2 AmbioPharm Business Overview
    • 11.4.3 AmbioPharm Peptide API CDMO Services Introduction
    • 11.4.4 AmbioPharm Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.4.5 AmbioPharm Recent Development
  • 11.5 USV Peptides
    • 11.5.1 USV Peptides Company Details
    • 11.5.2 USV Peptides Business Overview
    • 11.5.3 USV Peptides Peptide API CDMO Services Introduction
    • 11.5.4 USV Peptides Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.6 Thermo Fisher
    • 11.6.1 Thermo Fisher Company Details
    • 11.6.2 Thermo Fisher Business Overview
    • 11.6.3 Thermo Fisher Peptide API CDMO Services Introduction
    • 11.6.4 Thermo Fisher Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.7 Bio Basic
    • 11.7.1 Bio Basic Company Details
    • 11.7.2 Bio Basic Business Overview
    • 11.7.3 Bio Basic Peptide API CDMO Services Introduction
    • 11.7.4 Bio Basic Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.8 JPT
    • 11.8.1 JPT Company Details
    • 11.8.2 JPT Business Overview
    • 11.8.3 JPT Peptide API CDMO Services Introduction
    • 11.8.4 JPT Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.9 Genscript
    • 11.9.1 Genscript Company Details
    • 11.9.2 Genscript Business Overview
    • 11.9.3 Genscript Peptide API CDMO Services Introduction
    • 11.9.4 Genscript Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.9.5 Genscript Recent Development
  • 11.10 Chinese Peptide Company
    • 11.10.1 Chinese Peptide Company Company Details
    • 11.10.2 Chinese Peptide Company Business Overview
    • 11.10.3 Chinese Peptide Company Peptide API CDMO Services Introduction
    • 11.10.4 Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.11 ScinoPharm
    • 11.11.1 ScinoPharm Company Details
    • 11.11.2 ScinoPharm Business Overview
    • 11.11.3 ScinoPharm Peptide API CDMO Services Introduction
    • 11.11.4 ScinoPharm Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.11.5 ScinoPharm Recent Development
  • 11.12 ChengDu ShengNuo Biotec
    • 11.12.1 ChengDu ShengNuo Biotec Company Details
    • 11.12.2 ChengDu ShengNuo Biotec Business Overview
    • 11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Introduction
    • 11.12.4 ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.13 CBL
    • 11.13.1 CBL Company Details
    • 11.13.2 CBL Business Overview
    • 11.13.3 CBL Peptide API CDMO Services Introduction
    • 11.13.4 CBL Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.14 Piramal Pharma
    • 11.14.1 Piramal Pharma Company Details
    • 11.14.2 Piramal Pharma Business Overview
    • 11.14.3 Piramal Pharma Peptide API CDMO Services Introduction
    • 11.14.4 Piramal Pharma Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.15 CPC Scientific
    • 11.15.1 CPC Scientific Company Details
    • 11.15.2 CPC Scientific Business Overview
    • 11.15.3 CPC Scientific Peptide API CDMO Services Introduction
    • 11.15.4 CPC Scientific Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.15.5 CPC Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제